We first conducted genomic analyses of 489 human ovarian serous cystadenocarcinomas using the Cancer Genomics Atlas (TCGA), which revealed an inverse relationship between LRRC4 and PIK3R1 expression (Figure 4A). The gene discussed is LRRC4; the disease is ovarian serous cystadenocarcinoma.